• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sempra Appoints Jennifer M. Kirk to Board of Directors

    6/20/24 4:15:00 PM ET
    $MDT
    $SRE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Natural Gas Distribution
    Utilities
    Get the next $MDT alert in real time by email

    SAN DIEGO, June 20, 2024 /PRNewswire/ -- Sempra (NYSE:SRE) (BMV:SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024. Kirk is currently the global controller and chief accounting officer of Medtronic plc (NYSE:MDT) and has deep executive experience in finance, accounting and capital market activities, including more than 20 years in the energy industry.

    Jennifer M. Kirk

    "Bringing new perspectives into the boardroom is a critical component of our effort to support the company's mission to build North America's premier energy infrastructure company," said Jeffrey W. Martin, Sempra chairman and CEO. "Our board of directors embody a diverse set of skills, experiences and viewpoints that help guide Sempra's corporate strategy and overall business success. Jennifer's strong accounting and finance experience, coupled with her understanding of the energy business, will be a great complement to the board as we advance our corporate strategy and oversee financial discipline, risk management and ethical practices."

    Before joining Medtronic, Kirk, 49, worked at Occidental Petroleum Corporation for more than two decades, serving in roles of increasing responsibility, including senior vice president of integration and value capture, and vice president, controller and principal accounting officer.

    Kirk serves on the board of directors of Republic Services, where she is chair of the audit committee. She holds a bachelor's degree in economics from UC Santa Barbara and a master's degree in business administration from California State University, Bakersfield.

    With the appointment of Kirk, Sempra will have 10 directors with three having been newly elected over the past five years, reflecting the company's commitment to periodic board refreshment to ensure fresh and diverse perspectives are present in the boardroom. Kirk will serve on the board's audit committee and the safety, sustainability and technology committee.

    About Sempra

    Sempra (NYSE:SRE) is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California, Texas, Mexico and global energy markets. The company is recognized as a leader in sustainable business practices and for its high-performance culture focused on safety and operational excellence, as demonstrated by Sempra's inclusion in the Dow Jones Sustainability Index North America and in The Wall Street Journal's Best Managed Companies. More information about Sempra is available at sempra.com and on social media @Sempra.

     

    Sempra Logo (PRNewsfoto/Sempra)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sempra-appoints-jennifer-m-kirk-to-board-of-directors-302177421.html

    SOURCE Sempra

    Get the next $MDT alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDT
    $SRE

    CompanyDatePrice TargetRatingAnalyst
    Medtronic plc.
    $MDT
    6/30/2025Underperform → Peer Perform
    Wolfe Research
    Medtronic plc.
    $MDT
    6/16/2025$110.00Outperform
    Leerink Partners
    DBA Sempra
    $SRE
    4/9/2025$93.00 → $70.00Neutral
    Citigroup
    DBA Sempra
    $SRE
    3/18/2025Buy → Hold
    Argus
    Medtronic plc.
    $MDT
    3/4/2025$92.00 → $107.00Neutral → Buy
    Citigroup
    DBA Sempra
    $SRE
    3/3/2025$96.00 → $77.00Buy → Hold
    Jefferies
    DBA Sempra
    $SRE
    2/27/2025$95.00 → $72.00Overweight → Equal Weight
    Barclays
    DBA Sempra
    $SRE
    2/26/2025$95.00 → $78.00Buy → Neutral
    UBS
    More analyst ratings

    $MDT
    $SRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Medtronic upgraded by Wolfe Research

    Wolfe Research upgraded Medtronic from Underperform to Peer Perform

    6/30/25 7:56:30 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Leerink Partners initiated coverage on Medtronic with a new price target

    Leerink Partners initiated coverage of Medtronic with a rating of Outperform and set a new price target of $110.00

    6/16/25 7:51:25 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Citigroup reiterated coverage on Sempra Energy with a new price target

    Citigroup reiterated coverage of Sempra Energy with a rating of Neutral and set a new price target of $70.00 from $93.00 previously

    4/9/25 8:02:34 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jellison William R bought $462,750 worth of Ordinary Shares (5,000 units at $92.55) (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    8/25/25 5:18:06 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Ferrero Pablo bought $184,496 worth of shares (2,600 units at $70.96), increasing direct ownership by 20% to 15,649 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    3/17/25 9:10:57 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Director Conesa Andres bought $100,156 worth of shares (1,400 units at $71.54), increasing direct ownership by 7% to 21,668 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    3/17/25 9:10:19 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    $MDT
    $SRE
    SEC Filings

    View All

    $MDT
    $SRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Medtronic Announces Closing of Public Offering of €1.5 Billion of Senior Notes

    GALWAY, Ireland, Sept. 29, 2025 /PRNewswire/ -- Medtronic plc (the "Company") (NYSE: MDT) announced today that its wholly-owned indirect subsidiary, Medtronic, Inc., has closed a registered public offering (the "Offering") of €750,000,000 principal amount of 2.950% senior notes due 2030 and €750,000,000 principal amount of 4.200% senior notes due 2045 (collectively, the "Notes"). All of Medtronic, Inc.'s obligations under the Notes are fully and unconditionally guaranteed by the Company and Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), a wholly-owned subsidiary of the Company and the indirect parent of Medtronic, Inc., on a senior unsecured basis. The net proceeds from the Offering a

    9/29/25 8:09:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Sempra to Participate in the Wolfe Research Utilities, Midstream & Clean Energy Conference 2025

    SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- Sempra (NYSE: SRE) today announced that company management will participate in the Wolfe Research Utilities, Midstream & Clean Energy Conference 2025. Jeffrey W. Martin, chairman and CEO of Sempra, Karen Sedgwick, executive vice president and CFO of Sempra, Justin Bird, executive vice president of Sempra and CEO of Sempra Infrastructure, and Allen Nye, CEO of Oncor Electric Delivery Company LLC, will meet with investors during the conference. Martin will deliver a keynote presentation on Sept. 30, 2025, at 12 p.m. EST, highlighting Sempra's previously announced capital recycling transaction and strategic reinvestment of proceeds into its utility-focu

    9/26/25 4:44:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Sempra Announces Strategic Transactions Advancing Goal of Building Leading U.S. Utility Growth Business

    Agreement to Sell 45% of Sempra Infrastructure Partners for $10 billion in cashAccretive Transaction Improves Sempra's Financial StrengthEfficiently Funds 2025–2029 Capital Plan without Equity IssuancesReached Final Investment Decision for Port Arthur LNG Phase 2Hosting Conference Call at 11 a.m. ESTSAN DIEGO, Sept. 23, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) today announced several strategic actions that advance Sempra's corporate strategy. The company is executing on five value creation initiatives designed to simplify Sempra's business model, improve financial performance and reduce risk. The company expects these initiatives to strengthen its ability to deliver improved earnings growth wh

    9/23/25 7:55:00 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SEC Form 25-NSE filed by Medtronic plc.

    25-NSE - Medtronic plc (0001613103) (Subject)

    9/29/25 10:44:27 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form CERT filed by Medtronic plc.

    CERT - Medtronic plc (0001613103) (Filer)

    9/29/25 9:53:17 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 8-K filed by Medtronic plc.

    8-K - Medtronic plc (0001613103) (Filer)

    9/29/25 8:45:28 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Sagara Kevin C. sold $1,291,754 worth of shares (14,433 units at $89.50), decreasing direct ownership by 93% to 1,042 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    9/29/25 8:23:44 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Director Sagara Kevin C. sold $2,430,567 worth of shares (28,864 units at $84.21), decreasing direct ownership by 65% to 15,475 units (SEC Form 4)

    4 - SEMPRA (0001032208) (Issuer)

    9/15/25 8:33:51 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    EVP & President Cardiovascular Kiil Harry Skip sold $788,048 worth of Ordinary Shares (8,605 units at $91.58), decreasing direct ownership by 19% to 35,615 units (SEC Form 4)

    4 - Medtronic plc (0001613103) (Issuer)

    9/5/25 4:18:13 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $MDT
    $SRE
    Financials

    Live finance-specific insights

    View All

    Sempra Announces Strategic Transactions Advancing Goal of Building Leading U.S. Utility Growth Business

    Agreement to Sell 45% of Sempra Infrastructure Partners for $10 billion in cashAccretive Transaction Improves Sempra's Financial StrengthEfficiently Funds 2025–2029 Capital Plan without Equity IssuancesReached Final Investment Decision for Port Arthur LNG Phase 2Hosting Conference Call at 11 a.m. ESTSAN DIEGO, Sept. 23, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) today announced several strategic actions that advance Sempra's corporate strategy. The company is executing on five value creation initiatives designed to simplify Sempra's business model, improve financial performance and reduce risk. The company expects these initiatives to strengthen its ability to deliver improved earnings growth wh

    9/23/25 7:55:00 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    Sempra Declares Common and Preferred Dividends

    SAN DIEGO, Sept. 17, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) today announced that its board of directors has declared a $0.645 per share quarterly dividend on the company's common stock, which is payable Oct. 15, 2025, to common stock shareholders of record at the close of business on Oct. 1, 2025. Sempra's board of directors also declared a semi-annual dividend of $24.375 per share on the company's 4.875% Fixed-Rate Reset Cumulative Redeemable Perpetual Preferred Stock, Series C (the "Series C preferred stock"), which is payable Oct. 15, 2025, to Series C preferred stock shareholders of record at the close of business on Oct. 1, 2025. Sempra will redeem all of the outstanding shares of Serie

    9/17/25 5:14:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SoCalGas Declares Preferred Dividends

    LOS ANGELES, Aug. 28, 2025 /PRNewswire/ -- The board of directors of Southern California Gas Company (SoCalGas) has declared regular quarterly dividends for the preferred series stock of the company as follows: SoCalGas: Preferred Stock $0.375 per share Preferred Stock, Series A $0.375 per share The dividends are payable on October 15, 2025, to shareholders of record on September 10, 2025. About SoCalGas SoCalGas is the largest gas distribution utility in the United States, serving more than 21 million consumers across approximately 24,000 square miles of Central and Southern California. Our mission is: Safe, Reliable, and Affordable energy delivery today. Ready for tomorrow. SoCalGas is a r

    8/28/25 3:29:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by DBA Sempra

    SC 13G - SEMPRA (0001032208) (Subject)

    11/8/24 10:52:39 AM ET
    $SRE
    Natural Gas Distribution
    Utilities

    SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

    SC 13G/A - Medtronic plc (0001613103) (Subject)

    2/13/24 5:09:43 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by DBA Sempra (Amendment)

    SC 13G/A - SEMPRA (0001032208) (Subject)

    2/13/24 4:56:00 PM ET
    $SRE
    Natural Gas Distribution
    Utilities

    $MDT
    $SRE
    Leadership Updates

    Live Leadership Updates

    View All

    Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

    GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

    7/8/25 8:45:00 AM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Medtronic Board appoints Dr. Joon Lee as a new director

    GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

    6/23/25 4:15:00 PM ET
    $MDT
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Kayne Anderson Energy Infrastructure Fund Announces Appointment of New Independent Directors

    HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointments of Holli C. Ladhani and Michael N. Mears as independent directors of the Company, effective immediately. Following the retirements of Anne K. Costin and Albert L. Richey earlier this year, the appointments of Ms. Ladhani and Mr. Mears return the Company's Board to eight members, seven of whom are independent. Holli C. Ladhani is an experienced executive and board director in the energy, chemicals, power, and infrastructure sectors. Ms. Ladhani most recently served as President, Chief Executive Officer, and a member of the board of directors of

    5/27/25 4:15:00 PM ET
    $DVN
    $KYN
    $PWR
    Oil & Gas Production
    Energy
    Finance/Investors Services
    Finance